Portfolio company
PinCell
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops anti-inflammatory therapies and monoclonal antibodies for patients suffering from rare and severe skin diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brickell Bio
This pharmaceutical company develops prescription therapeutics for patients with autoimmune, inflammatory and debilitating skin diseases.
Castle Creek Biosciences
This company develops cell and gene therapies for patients suffering from rare genetic skin and connective tissue diseases.
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Mariposa Therapeutics
This biotechnology company develops a topical small-molecule therapy for patients with the rare genetic skin condition epidermolysis bullosa simplex.
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
SciRhom
This biopharmaceutical company develops monoclonal antibodies targeting iRhom2 to treat patients with autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
AllInBio
The company develops precision immunology therapies to identify and treat patients genetically predisposed to chronic inflammatory and autoimmune diseases.
